Nippon India Pharma Fund IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 10-May-2004
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 9279.11
Nippon India Pharma Fund IDCW - Nav Details
Nav Date
: 13-Aug-2026
NAV [Rs.]
: 124.0475
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
:
Nippon India Pharma Fund IDCW- NAV Chart
Nippon India Pharma Fund IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.58 | 2.39 | 8 | 14.31 | 10.85 | 17.98 | 13.44 | 19.88 |
| Category Avg | 0.63 | 3.35 | 11.74 | 20.82 | 16.23 | 21.19 | 15.23 | 17.92 |
| Category Best | 2.39 | 6.25 | 16.17 | 26.1 | 24.98 | 24.59 | 19.06 | 32.08 |
| Category Worst | -0.46 | 1.06 | 6.76 | 9.95 | 4.04 | 17.07 | 11.85 | 6.51 |
Nippon India Pharma Fund IDCW- Latest Dividends
Record DateDividend %Bonus
03-Feb-2026850
Nippon India Pharma Fund IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.31 | 6206349 | 1,235.37 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.25 | 2783991 | 672.33 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.52 | 750754 | 604.80 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.03 | 3795054 | 559.08 |
| Equity | Apollo Hospitals | Healthcare Services | 5.30 | 548795 | 491.55 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.01 | 4049746 | 464.95 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.74 | 1404429 | 346.83 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.62 | 2555745 | 336.10 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.41 | 913918 | 316.69 |
| Equity | Max Healthcare | Healthcare Services | 3.15 | 2658082 | 291.99 |
| Equity | Medplus Health | Retailing | 2.69 | 3545229 | 249.92 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.66 | 928841 | 246.64 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.57 | 1364742 | 238.52 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.51 | 4016627 | 232.56 |
| Equity | Vijaya Diagnost. | Healthcare Services | 2.42 | 1671618 | 224.73 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.24 | 74802 | 207.94 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.16 | 800549 | 200.36 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 2.09 | 9937272 | 194.38 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.05 | 1000578 | 190.63 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.01 | 323678 | 186.16 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.80 | 823911 | 167.18 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.65 | 318249 | 153.52 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.58 | 746337 | 146.28 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 1.54 | 902630 | 142.63 |
| Equity | Syngene Intl. | Healthcare Services | 1.46 | 3501497 | 135.12 |
| Equity | Fortis Health. | Healthcare Services | 1.37 | 1346128 | 127.20 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.07 | 300272 | 99.63 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.06 | 3896349 | 98.24 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.06 | 213659 | 98.52 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 1.00 | 1405283 | 92.51 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.92 | 1058503 | 85.65 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.92 | 2004071 | 85.31 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.55 | 62568 | 50.68 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.43 | 1834924 | 40.27 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.17 | 111738 | 15.87 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
